(Q57912068)

4

object named as

Michael Detmar

0 references

author name string

Eveline Trachsel

1

0 references

Manuela Kaspar

2

0 references

Frank Bootz

Journal of Investigative Dermatology

3

0 references

language of work or name

English

0 references

publication date

April 2007

0 references

published in

0 references

volume

127

0 references

issue

4

0 references

page(s)

881-886

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.jid.5700653

0 references

cites work

Antibody-directed enzyme prodrug therapy (ADEPT) for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Emerging therapeutic targets in psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Radioimmunodetection and radioimmunotherapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Selective targeted delivery of TNFalpha to tumor blood vessels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Molecular targeting of angiogenesis for imaging and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Three-dimensional reconstruction of endothelial cell gaps in psoriatic vessels and their morphologic identity with gaps produced by the intradermal injection of histamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Initial events in psoriasis: quantitative assessment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

ED-B fibronectin as a target for antibody-based cancer treatments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Tumour vascular targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Arming antibodies: prospects and challenges for immunoconjugates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021

Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700653

7 January 2021